MKI67 and neoplasm: After 30 days of implantation, 8 out of the 9 mice injected with U87-miR-4310 cells had larger tumor burdens (Fig. 2a) and displayed higher expression of Ki67 and proliferating cell nuclear antigen (PCNA) in tumor tissues relative to controls (Fig. 2b).